Invitation to Lecture to be delivered by: Professor Nicholas TalleyDirector of NHMRC Centre of Research Excellence in Digestive HealthDistinguished Laureate Professor (University of Newcastle)
Date: November 9 2022 12.30pm-1.30pm, Lunch from 12noonTitle: 'Beyond E0E: Eosinophils in GI disease – New Insights, “new” disease'Venue: Wingate Institute for Neurogastroenterology, 26 Ashfield Street, Whitechapel, London
Biography:
With a number of world-firsts and achievements in gastroenterological research, the Pro Vice-Chancellor, Global Research at the University of Newcastle believes each of his discoveries together paint a hypothesis for gut disorders and general health.
Professor Talley, who is also past president of the Royal Australasian College of Physicians (2014-2016), said this research provides a paradigm shift in the causes of a number of diseases.
His research team are amongst the first “to discover a genetic mutation in a subset of Irritable Bowel Syndrome (IBS) to a pathological link between bacteria and functional dyspepsia are helping explain the unexplained. What is most interesting is what this research is also showing us about other disorders," he said.
Professor Talley and his team are investigating cytokine profiling through a National Health and Medical Research Council grant and said that answers to many diseases lies in this research.
Listing over 1,000 publications and receiving more than $10 million in grants, Professor Talley's expertise has seen him receive numerous awards and accolades, including the 2014 American Gastroenterological Association Distinguished Educator Award. Professor Talley is also the author of the highly regarded textbooks Clinical Examination and Examination Medicine with Dr Simon O'Connor.
An academic clinician, researcher and scientist, Professor Talley has built a growing reputation of excellence for gastroenterology research at the University of Newcastle and the Hunter Medical Research Institute.
Professor Talley's impressive record includes recently discovering the bowel disease, duodenal eosinophilia. The disease is found in 40 per cent of people suffering from functional dyspepsia, a previously unexplained and severe form of indigestion that displays burning symptoms.
The discovery of duodenal eosinophilia was a critical breakthrough and Professor Talley and his team are now testing a novel therapeutic strategy that could provide a new treatment.
Quoted From: https://www.newcastle.edu.au/profile/nicholas-talley
NJT Short CV Aug2022 [PDF 4,823KB]
Please respond back to Samantha Pimm s.j.pimm@qmul.ac.uk asap if you are able/not able to attend for catering purposes please.